These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 27435511)

  • 1. Specific aspects of a combined approach to male face correction: botulinum toxin A and volumetric fillers.
    Scherer MA
    J Cosmet Dermatol; 2016 Dec; 15(4):566-574. PubMed ID: 27435511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facial Contouring With Fillers, Neuromodulators, and Lipolysis to Achieve a Natural Look in Patients With Facial Fullness.
    Anand C
    J Drugs Dermatol; 2016 Dec; 15(12):1536-1542. PubMed ID: 28095576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Aging Face: Global Approach With Fillers and Neuromodulators.
    Solish N
    Semin Cutan Med Surg; 2016 Jun; 35(6 Suppl):S120-1. PubMed ID: 27537350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periorbital Surgery: Forehead, Brow, and Midface.
    Chi JJ
    Facial Plast Surg Clin North Am; 2016 May; 24(2):107-17. PubMed ID: 27105796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periorbital Rejuvenation: Overview of Nonsurgical Treatment Options.
    Glaser DA; Kurta A
    Facial Plast Surg Clin North Am; 2016 May; 24(2):145-52. PubMed ID: 27105800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic approaches for the treatment of facial aging].
    Gauglitz GG; Podda M
    Hautarzt; 2015 Oct; 66(10):738-43. PubMed ID: 26349682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers: Focus on the Upper Face.
    de Maio M; Swift A; Signorini M; Fagien S;
    Plast Reconstr Surg; 2017 Aug; 140(2):265e-276e. PubMed ID: 28746271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comprehensive Approach to Multimodal Facial Aesthetic Treatment: Injection Techniques and Treatment Characteristics From the HARMONY Study.
    Narurkar VA; Cohen JL; Dayan S; Kaminer MS; Rivkin A; Shamban A; Sykes JM; Teller CF; Weinkle SH; Werschler WP; Drinkwater A; Pucci ML; Gallagher CJ
    Dermatol Surg; 2016 May; 42 Suppl 2():S177-91. PubMed ID: 27128246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum neurotoxins and injectable fillers: minimally invasive management of the aging upper face.
    Maas CS
    Facial Plast Surg Clin North Am; 2006 Aug; 14(3):241-5. PubMed ID: 16908391
    [No Abstract]   [Full Text] [Related]  

  • 10. Injectable treatments for the aging face.
    Wise JB; Greco T
    Facial Plast Surg; 2006 May; 22(2):140-6. PubMed ID: 16847805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on botulinum toxin.
    Flynn TC
    Semin Cutan Med Surg; 2007 Dec; 26(4):196-202. PubMed ID: 18395667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsurgical correction of drooping mouth corners using monophasic hyaluronic acid and incobotulinumtoxinA.
    Bae GY; Na JI; Park KC; Cho SB
    J Cosmet Dermatol; 2020 Feb; 19(2):338-345. PubMed ID: 31125173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimally Invasive Facial Cosmetic Procedures.
    Devgan L; Singh P; Durairaj K
    Otolaryngol Clin North Am; 2019 Jun; 52(3):443-459. PubMed ID: 30954270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global Aesthetics Consensus: Hyaluronic Acid Fillers and Botulinum Toxin Type A-Recommendations for Combined Treatment and Optimizing Outcomes in Diverse Patient Populations.
    Sundaram H; Liew S; Signorini M; Vieira Braz A; Fagien S; Swift A; De Boulle KL; Raspaldo H; Trindade de Almeida AR; Monheit G;
    Plast Reconstr Surg; 2016 May; 137(5):1410-1423. PubMed ID: 27119917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation.
    Carruthers A; Carruthers J; Monheit GD; Davis PG; Tardie G
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2121-34. PubMed ID: 21134044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient Satisfaction and Efficacy of Full-Facial Rejuvenation Using a Combination of Botulinum Toxin Type A and Hyaluronic Acid Filler.
    Molina B; David M; Jain R; Amselem M; Ruiz-Rodriguez R; Ma MY; Kerrouche N; Georgantopoulos SP; Radeau T; Boineau D
    Dermatol Surg; 2015 Dec; 41 Suppl 1():S325-32. PubMed ID: 26618460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type A for facial aesthetic enhancement: role in facial shaping.
    Fagien S
    Plast Reconstr Surg; 2003 Oct; 112(5 Suppl):6S-18S; discussion 19S-20S. PubMed ID: 14504481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Older women's negative psychological and physical experiences with injectable cosmetic treatments to the face.
    Berwick S; Humble Á
    J Women Aging; 2017; 29(1):51-62. PubMed ID: 27715903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers: Focus on the Lower Face.
    de Maio M; Wu WTL; Goodman GJ; Monheit G;
    Plast Reconstr Surg; 2017 Sep; 140(3):393e-404e. PubMed ID: 28841604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facial Contouring by Using Dermal Fillers and Botulinum Toxin A: A Practical Approach.
    Farolch-Prats L; Nome-Chamorro C
    Aesthetic Plast Surg; 2019 Jun; 43(3):793-802. PubMed ID: 30953112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.